Dmg Group, LLC Bristol Myers Squibb CO Transaction History

Dmg Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$47.98 - $54.4 $11,371 - $12,892	-237 Reduced 3.47%	6,597 $357,000
Q4 2023 Jan 10, 2024	SELL	$48.48 - $57.85 $137,198 - $163,715	-2,830 Reduced 29.28%	6,834 $350,000
Q3 2023 Oct 26, 2023	SELL	$57.89 - $64.73 $26,976 - $30,164	-466 Reduced 4.6%	9,664 $560,000
Q2 2023 Jul 13, 2023	SELL	$63.71 - $70.74 $21,661 - $24,051	-340 Reduced 3.25%	10,130 $647,000
Q4 2022 Feb 06, 2023	SELL	$68.48 - $81.09 $29,788 - $35,274	-435 Reduced 3.99%	10,470 $757,000
Q3 2022 Oct 27, 2022	SELL	$0.13 - $76.84 $123 - $72,921	-949 Reduced 8.01%	10,905 $769,000
Q2 2022 Aug 09, 2022	SELL	$72.62 - $79.98 $3,558 - $3,919	-49 Reduced 0.41%	11,854 $912,000
Q1 2022 Apr 25, 2022	SELL	$61.48 - $73.72 $196,613 - $235,756	-3,198 Reduced 21.18%	11,903 $902,000
Q4 2021 Jan 31, 2022	BUY	$53.63 - $62.52 $809,866 - $944,114	15,101 New	15,101 $964,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Dmg Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Dmg Group, LLC with notifications on news.